Company · CIK 0001681689
Bioverativ Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ABioverativ Inc.0001104659-18-023188 · 70.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-18-015757 · 170.0 KBSEC(opens sec.gov)
- 10-K/ABioverativ Inc.0001558370-18-001682 · 1.1 MBSEC(opens sec.gov)
- SC 13G/ABioverativ Inc.0001104659-18-012374 · 70.3 KBSEC(opens sec.gov)
- SC 13G/ABioverativ Inc.0001144204-18-008643 · 152.3 KBSEC(opens sec.gov)
- 10-KAnnual report0001558370-18-000672 · 11.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-18-000636 · 1.1 MBSEC(opens sec.gov)
- SC 13GBioverativ Inc.0000932471-18-002711 · 45.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001681689-18-000003 · 174.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-18-003187 · 899.4 KBSEC(opens sec.gov)
Insiders
- BIOGEN INC.10% Owner
- Brudnick RichardEVP, Business Development
- Celona LuciaEVP, HR & Corp Commun. Officer
- Cox JohnDirector, Chief Executive Officer
- DENNER ALEXANDER JDirector
- DiFabio AndreaEVP, Chief Legal Officer
- Duvall DianthaChief Accounting Officer
- Germano Geno JDirector
- Greene JohnEVP, CFO and Treasurer
- Harris Timothy J.R.EVP, R & D
Tickers
No tickers on record.
Addresses
business
225 2ND AVENUE
WALTHAM, MA, 02451
mailing
225 2ND AVENUE
WALTHAM, MA, 02451
Same industry